Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Nothing new posted on USPTO for '148(90/008,227), '336(90/008,237, 90/009,457)

It looks like yet another re-ex request based on prior art involving Uhlenhoff in combination with Ledzius instead of Kato and Ledzius(which was addressed in the original re-ex) that resulted in amendments to claims which should put the '336 in (or closer to) a condition for a re-cert.

This is way over my head and analysis from a techie is needed here. Read the "Receipt of Orig. Ex Parte Request by Third Party" in IFW.

Bottom line....HTC, Acer, Barco & Sirius together are taking a shot at invalidating the patent any way they can. I hope examiner Rimmell makes short work of denying this request as well. Is there no end to how many 3rd party requests are taken into consideration?

All IMHO and comments are welcomed.

GLTAL

Share
New Message
Please login to post a reply